A Clinical Study Evaluating the Effects of Fluvastatin on Serum Osteoprotegerin Levels in Rheumatoid Arthritis Patients.

about

A Clinical Study Evaluating the Effects of Fluvastatin on Serum Osteoprotegerin Levels in Rheumatoid Arthritis Patients.

Item

http://www.wikidata.org/entity/Q53771696

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

A Clinical Study Evaluating th ...... Rheumatoid Arthritis Patients.

@en

A Clinical Study Evaluating th ...... Rheumatoid Arthritis Patients.

@nl

type

Item

label

A Clinical Study Evaluating th ...... Rheumatoid Arthritis Patients.

@en

A Clinical Study Evaluating th ...... Rheumatoid Arthritis Patients.

@nl

prefLabel

A Clinical Study Evaluating th ...... Rheumatoid Arthritis Patients.

@en

A Clinical Study Evaluating th ...... Rheumatoid Arthritis Patients.

@nl

P1476

A Clinical Study Evaluating th ...... Rheumatoid Arthritis Patients.

@en

P2093

Marwa El-Saeed El-Hefnawy

http://www.w3.org/2001/XMLSchema#string

Sahar Kamal Hegazy

http://www.w3.org/2001/XMLSchema#string

Salwa El-Morsy Abd El-Ghany El-Sayed

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Effect of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor on disease activity in patients with rheumatoid arthritis: a meta-analysis

Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis

Discovery, biochemistry and biology of lovastatin.

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

ICSH review of the measurement of the erythocyte sedimentation rate.

Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis.

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology.

Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

P304

1272-1276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.725

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26899523

http://www.w3.org/2001/XMLSchema#string